Research Topics
| A R ZanettiSummaryAffiliation: University of Milan Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in ItalyAlessandro Zanetti
Dipartimento di Scienze Biomediche per la Salute, Universita degli Studi di Milano, Via Carlo Pascal, 36, 20133 Milano, Italy
Vaccine 30:5770-5. 2012..This study investigated responses to a challenge dose of monovalent hepatitis B vaccine in children immunised with three doses of either Hexavac or Infanrix-Hexa during infancy...
Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern ItalyGianvincenzo Zuccotti
Department of Paediatrics, Luigi Sacco Hospital, Universita di Milano, Milan, Italy
BMC Infect Dis 10:218. 2010..Rotavirus is the major cause of acute gastroenteritis and severe dehydrating diarrhea in young children...
Primary prevention of hepatitis C virus infectionAlessandro R Zanetti
Institute of Virology, Faculty of Medicine, University of Milan, Milan, Italy
Vaccine 21:692-5. 2003..Health education, counselling and testing of individuals at risk provide opportunities for controlling HCV infection...- Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapyAlessandro R Zanetti
Istituto di Virologia, Universita degli Studi, Milano, Italy
J Med Virol 70:27-30. 2003..In addition, with the advent of additional treatment protocols, a rapid, reliable assay for changes in HCV load may permit more frequent patient assessment and tailoring of the therapeutic regimen... - Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre studyAlessandro Remo Zanetti
Istituto di Virologia, Universita di Milano, Milan, Italy
Lancet 366:1379-84. 2005..We undertook a multicentre study in previously vaccinated individuals to assess the duration of immunity and need for booster, over 10 years after vaccination... - Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supplyAlessandro R Zanetti
Department of Public Health Microbiology Virology, University of Milan, Italy
J Clin Virol 36:S51-5. 2006..There is agreement that, at present, the implementation of HBV DNA testing will not allow for discontinuation of screening for HBsAg... - The global impact of vaccination against hepatitis B: a historical overviewAlessandro R Zanetti
Department of Public Health Microbiology Virology, Faculty of Medicine, University of Milan, Via C Pascal 36, 20133 Milan, Italy
Vaccine 26:6266-73. 2008..A future challenge is to overcome the social and economic hurdles which still hamper the introduction of hepatitis B vaccination on a global scale... - Emerging and re-emerging infections at the turn of the millenniumA R Zanetti
Dipartimento di Sanità Pubblica Microbiologia Virologia, Universita degli Studi di Milano, Via C Pascal 36, 20133 Milan, Italy
Haemophilia 16:7-12. 2010..The end of the war against infectious diseases is not in sight. Mankind's battle with pathogens has lasted millennia and is destined to continue... - Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre studyAlessandro Remo Zanetti
Department of Public Health Microbiology Virology, University of Milan, Milan, Italy
Lancet Infect Dis 10:755-61. 2010..In 2005, hexavac was suspended because of concerns about the long-term immunogenicity of its hepatitis B component. We aimed to assess the duration of immunity and need for booster injections in children primed with these vaccines... - Safety and immunogenicity of influenza vaccination in individuals infected with HIVAlessandro R Zanetti
Institute of Virology, University of Milan, Via Pascal 38, Milan 20133, Italy
Vaccine 20:B29-32. 2002..Therefore, vaccination against influenza can be safely administered to HIV infected people... - Mother-to-infant transmission of hepatitis C virusA R Zanetti
Institute of Virology, University of Milan, Italy
J Hepatol 31:96-100. 1999..Pregnancy is not contra-indicated in HCV-infected women. Without drugs to treat established infections in mothers and infants and interventions to prevent vertical transmission, routine HCV screening is not recommended in pregnant women... - Update on hepatitis B vaccination in Italy 10 years after its implementationA R Zanetti
Institute of Virology, University of Milan, Via C Pascal 38, 20133, Milan, Italy
Vaccine 19:2380-3. 2001.... - Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug usersA Amendola
Institute of Virology, University of Milan, Milan, Italy
J Med Virol 65:644-8. 2001..Immunization caused no significant changes in CD4+ counts and in neither plasma HIV-1 RNA nor proviral DNA levels. Therefore, vaccination against influenza may benefit persons infected by HIV-1... - Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug usersA Amendola
Institute of Virology, University of Milan, Via Pascal 38, 20133, Milan, Italy
Vaccine 20:3720-4. 2002..Pneumococcal vaccination does not induce virological or immunological deterioration in HIV infected patients, but the antibody response to a single dose of vaccine is poor... - Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses TransmissionA R Zanetti
Institute of Virology, University of Milan, Italy
J Med Virol 54:107-12. 1998..The infection is transmitted efficiently from mother to baby and rate of transmission is much higher than that for HCV. GBV-C can cause persistent infection in babies but usually without clear evidence of liver disease... - Identification of a novel variant of hepatitis E virus in ItalyA R Zanetti
Institute of Virology, University of Milan, Italy
J Med Virol 57:356-60. 1999..However, the identification of a new HEV variant in an individual who never indicated travel or contact with individuals associated with endemic areas, suggests that this virus may be native to Italy... - Decline in anti-HAV prevalence in the Milan area between 1958 and 1992A R Zanetti
Institute of Virology, University of Milan, Italy
Eur J Epidemiol 10:633-5. 1994..The results show a dramatic reduction of HAV circulation likely due to the considerable improvement of socioeconomic and hygienic living conditions which have occurred in Italy during the last decades... - GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in ItalyL Romano
Institute of Virology, University of Milan, Milan, Italy
J Med Virol 61:59-64. 2000..Concomitant GBV-C/HGV and HBV or HCV infection does not worsen the clinical course of illness among patients with acute hepatitis... - Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemiaR Cimaz
Clinica Pediatrica De Marchi, Istituti Clinici di Perfezionamento, 20122 Milan, Italy
J Infect Dis 183:1819-21. 2001..Hib conjugate vaccine is safe and immunogenic in patients with thalassemia major; however, additional studies are needed to assess the need and timing of booster vaccination to maintain long-term immunity... - [Seroepidemiology of varicella in a cohort of Italian adolescents]L Romano
Istituto di Virologia, Universita degli Studi di Milano
Ann Ig 14:7-10. 2002 - Early co-circulation of different clades of influenza A/H1N1v pandemic virus in northern ItalyE Pariani
Department of Public Health Microbiology Virology, University of Milan, Italy
J Prev Med Hyg 52:17-20. 2011..About 45% of analyzed samples were laboratory-confirmed cases of A/HINlv. Sporadic cases occurred until the middle of June 2009, then, case numbers began to increase delineating distinct epidemiological phases of viral circulation... - The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccinationLuisa Romano
Department of Public Health Microbiology Virology, University of Milan, Via C Pascal 36, 20133 Milano, Italy
Vaccine 27:3439-42. 2009..An additional benefit of hepatitis B vaccination is that hepatitis Delta has also substantially declined... - Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studiesAlberto Larghi
Division of Internal Medicine, Department of Medicine, Surgery and Dentistry, Ospedale San Paolo, Italy
Hepatology 36:993-1000. 2002..In conclusion, our homogeneous cohort showed a wide spectrum of clinical, virologic and histologic features, and, more importantly, short-term outcome differed noticeably despite the common source of infection... - Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year surveyClaudio Velati
Department of Transfusion Medicine and Haematology, Hospital of Sondrio, Sondrio, Italy
Transfusion 48:2205-13. 2008.... - Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birthMaria Antonietta Casiraghi
Liver Unit, Department of Medicine, Hospital of Legnano, Milan, Italy
Hepatology 39:90-6. 2004..In conclusion, taking into account the limited study sample, these findings suggest that HCV infection acquired early in life shows a slow progression and mild outcome during the first 35 yr of infection...